| Primary |
| Depression |
43.4% |
| Anxiety |
19.2% |
| Panic Attack |
7.4% |
| Ill-defined Disorder |
3.2% |
| Major Depression |
3.2% |
| Panic Disorder |
3.0% |
| Social Phobia |
2.6% |
| Sleep Disorder |
2.3% |
| Bipolar Disorder |
2.1% |
| Thyroid Disorder |
2.1% |
| Hypertension |
1.7% |
| Agoraphobia |
1.5% |
| Obsessive-compulsive Disorder |
1.3% |
| Pain |
1.3% |
| Headache |
1.1% |
| Asthma |
0.9% |
| Dyspnoea |
0.9% |
| Phobia |
0.9% |
| Tremor |
0.9% |
| Hypersensitivity |
0.8% |
|
| Drug Ineffective |
17.3% |
| Weight Increased |
17.3% |
| Weight Decreased |
7.1% |
| Withdrawal Syndrome |
7.1% |
| Insomnia |
5.8% |
| Pharmaceutical Product Complaint |
5.3% |
| Surgery |
4.9% |
| Headache |
4.0% |
| Malaise |
3.6% |
| Drug Effect Decreased |
2.7% |
| Hypertension |
2.7% |
| Hypertensive Crisis |
2.7% |
| Oedema Peripheral |
2.7% |
| Sleep Disorder |
2.7% |
| Tremor |
2.7% |
| Vision Blurred |
2.7% |
| Depression |
2.2% |
| Drug Interaction |
2.2% |
| Nasopharyngitis |
2.2% |
| Pain |
2.2% |
|
| Secondary |
| Depression |
38.2% |
| Anxiety |
29.3% |
| Panic Attack |
4.1% |
| Headache |
3.0% |
| Sleep Disorder |
2.5% |
| Drug Use For Unknown Indication |
2.3% |
| Generalised Anxiety Disorder |
2.3% |
| Hypertension |
2.2% |
| Social Phobia |
2.1% |
| Post-traumatic Stress Disorder |
1.9% |
| Asthma |
1.8% |
| Product Used For Unknown Indication |
1.6% |
| Panic Disorder |
1.3% |
| Cardiac Disorder |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Hyperchlorhydria |
1.2% |
| Agoraphobia |
1.0% |
| Phobia |
1.0% |
| Major Depression |
0.9% |
| Obsessive-compulsive Disorder |
0.9% |
|
| Weight Increased |
18.9% |
| Drug Ineffective |
11.9% |
| Oedema Peripheral |
10.5% |
| Vomiting |
7.7% |
| Withdrawal Syndrome |
7.0% |
| Weight Decreased |
6.3% |
| Thrombosis |
4.2% |
| Memory Impairment |
3.5% |
| Panic Attack |
3.5% |
| Surgery |
3.5% |
| Headache |
2.8% |
| Hypertension |
2.8% |
| Insomnia |
2.8% |
| Blood Potassium Decreased |
2.1% |
| Drug Effect Decreased |
2.1% |
| Hypertensive Crisis |
2.1% |
| Mental Disorder |
2.1% |
| Panic Disorder |
2.1% |
| Product Odour Abnormal |
2.1% |
| Skin Disorder |
2.1% |
|
| Concomitant |
| Depression |
20.2% |
| Drug Use For Unknown Indication |
15.1% |
| Anxiety |
7.8% |
| Hypertension |
7.3% |
| Osteoporosis |
6.2% |
| Product Used For Unknown Indication |
6.2% |
| Bipolar Disorder |
4.6% |
| Blood Cholesterol |
4.6% |
| Osteopenia |
4.6% |
| Sleep Disorder |
3.2% |
| Blood Cholesterol Increased |
2.7% |
| Pain |
2.7% |
| Asthma |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Hypothyroidism |
1.9% |
| Arthralgia |
1.6% |
| Arthritis |
1.6% |
| Bipolar I Disorder |
1.6% |
| Constipation |
1.6% |
| Headache |
1.6% |
|
| Wrist Fracture |
22.1% |
| Type 2 Diabetes Mellitus |
11.7% |
| Weight Increased |
6.5% |
| Drug Ineffective |
5.2% |
| Tachycardia |
5.2% |
| Headache |
3.9% |
| Hypertension |
3.9% |
| Jugular Vein Distension |
3.9% |
| Pneumonia |
3.9% |
| Pulmonary Embolism |
3.9% |
| Vision Blurred |
3.9% |
| White Blood Cell Count Decreased |
3.9% |
| Wound Dehiscence |
3.9% |
| Depression |
2.6% |
| Dizziness |
2.6% |
| Hypersomnia |
2.6% |
| Knee Arthroplasty |
2.6% |
| Loss Of Consciousness |
2.6% |
| Nausea |
2.6% |
| Nephrolithiasis |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
14.9% |
| Panic Attack |
11.9% |
| Agoraphobia |
9.0% |
| Thyroid Disorder |
9.0% |
| Hypertension |
6.0% |
| Pain |
6.0% |
| Panic Disorder |
6.0% |
| Depression |
4.5% |
| Anxiety |
3.0% |
| Arthritis Infective |
3.0% |
| Asthma |
3.0% |
| Blood Cholesterol Increased |
3.0% |
| Cardiac Disorder |
3.0% |
| Constipation |
3.0% |
| Hypersensitivity |
3.0% |
| Hypovitaminosis |
3.0% |
| Muscle Spasms |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Bursitis |
1.5% |
| Hypothyroidism |
1.5% |
|
| Tonic Clonic Movements |
16.7% |
| Drug Ineffective |
12.5% |
| Drug Interaction |
12.5% |
| Heart Rate Abnormal |
12.5% |
| Pain In Extremity |
8.3% |
| Serotonin Syndrome |
8.3% |
| Thyroid Disorder |
8.3% |
| Nausea |
4.2% |
| Rash |
4.2% |
| Urinary Tract Infection |
4.2% |
| Vision Blurred |
4.2% |
| Weight Increased |
4.2% |
|
